• Skip to main content
  • Skip to header right navigation
  • Skip to site footer
IMCS

IMCS

Integrated Micro-Chromatography Systems, Inc (IMCS) is a biotechnology company focused on delivering tools and services to...

  • ABOUT
    • ABOUT IMCS
    • QUALITY POLICY
    • RESEARCH AT IMCS
    • CAREERS
  • PRODUCTS
    • IMCSzyme®
      • IMCSzyme E1F
      • IMCSzyme RT
      • IMCSzyme® CATALOG
    • IMCStips®
      • APPLICATIONS
        • AFFINITY
        • SIZE EXCLUSION
        • NUCLEIC ACIDS
        • ION EXCHANGE
        • REVERSE PHASE
        • PHOSPHOPEPTIDE
      • IMCStips® CATALOG
      • AUTOMATION PLATFORMS
        • DYNAMIC DEVICES
        • HAMILTON
        • INTEGRA
        • TECAN
        • OPENTRONS
        • ANALYTIK JENA
    • SULFATASES
      • Sulfazyme™ PaS
      • Sulfazyme™ DS
      • Sulfazyme™ β-AS
    • GLYCO REAGENTS
      • GLYCOLIPIDS
      • ACTIVATED SUGARS
      • BIOSYNTHETIC ENZYMES
      • SMALL MOLECULES
    • OTHER PROTEINS
      • PURIFIED STREPTAVIDIN
      • B. pi. β-glucuronidase variant
  • SERVICES
    • BETA-GLUCURONIDASES & SULFATASES
      • β-GLUCURONIDASE VALIDATION SERVICES
      • HIGH-THROUGHPUT TOXICOLOGY WORKFLOWS
    • IMCStips®
      • SAMPLE PREPARATION AUTOMATION
      • HIGH-THROUGHPUT METHOD DEVELOPMENT
      • AUTOMATION PLATFORMS
        • DYNAMIC DEVICES
        • HAMILTON
        • INTEGRA
        • TECAN
        • OPENTRONS
        • ANALYTIK JENA
    • OTHER SERVICES
      • GLYCAN PRODUCTION (Coming Soon)
      • R&D COLLABORATIONS
      • EXTRACELLULAR VESICLES
  • RESOURCES
    • FAQ
    • IMCSZYME RESOURCES
    • IMCSTIPS RESOURCES
    • SAFETY DATA SHEETS
    • CERTIFICATE OF ANALYSIS
  • LATEST NEWS
    • LATEST NEWS
    • PODCAST
    • BLOG
    • EVENTS
    • WEBINARS
  • CONTACT
  • en
    • en
    • es
    • fr
    • de
    • zh-CN
Image of blue rendered molecular structure

IMCSZYME RESOURCES

LATEST RESOURCES

Review and download IMCSzyme resources below.

FLYERS Application Notes Poster Presentations Poster Summaries Webinars
FLYERS

IMCSzyme RT Facts

IMCSzyme RT Hydrolysis Performance

IMCSzyme RT Stability
Application Notes
  • In-well hydrolysis of urine at room temperature for drug testing
  • Simplifying Urine Drug Testing by Combining IMCSzyme® RT and β-Gone™ Plus β-Glucuronidase Removal Sample Preparation
  • Hydrolyzing 30,000 ng/mL of Codeine-6- β-Glucuronide in 15 minutes with Greater than 80% Efficiency Using IMCSzyme®
  • Improving Benzodiazepine Immunoassay Sensitivity by Rapid Glucuronide Hydrolysis Technology
Poster Presentations
  • SOFT 2024: β-Glucuronidase Kinetics on Morphine-3β-Glucuronide

  • SOFT 2023: Chemicals in Urine Can Reduce Glucuronide Hydrolysis Efficiency Causing False Negatives for Drug of Abuse Analysis

  • MSACL 2023: Insufficient Amount of Glucuronidase in Clinical Samples Can Result in Lowered Recoveries

  • SOFT 2022: Natural inhibitors in urine can reduce glucuronidase performance and result in lowered recoveries
  • ASMS 2022: Searching for a Better Glucuronidase Resulted in Finding Glucuronidases with Substrate Preferences

  • MSACL 2022: Reduced Hydrolysis Due to Natural Chemicals Inhibiting Glucuronidase Activity Resulting in Poor Liberation of Aglycones

  • SOFT 2021: Overcoming Heterogeneity in Urine Specimens: Avoiding False Negatives caused by Endogenous Inhibitors

  • SOFT 2020: Urine Variability Compromises β-Glucuronidase Performance Causing Inaccurate Drug Quantitation

  • SOFT 2019: Rapid Room Temperature Hydrolysis of Glucuronidated Drugs of Abuse using IMCSzyme® RT

  • ASMS 2019: Hydrolysis of Sulfated Steroids, Toxic Endobiotics and Xenobiotics Using Purified Sulfatase for Quantitation of Sulfated and Unconjugated Compounds

  • SOFT 2018: Rapid Hydrolysis of Glucuronidated Opiates and Opioids in Urine Using IMCSzyme®

  • SOFT 2018: Degradation and Conversion of Opioids and Opiates During Acid Hydrolysis

  • SOFT 2017: The Importance of pH in β-Glucuronidase Hydrolysis Efficiency

  • SOFT 2017: Enzyme Activities (Fishman Units) Correlate Poorly with Hydrolysis Efficiencies

  • ASMS 2017: Utilizing Purified β-Glucuronidase and Arylsulfatase to Accurately Quantitate Metabolites in Human Urine

Poster Summaries
  • A summary of “Buprenorphine Hydrolysis Using a Novel Recombinant  β-glucuronidase for Urine Drug Testing”

  • A summary of “Rapid Enzyme Hydrolysis Using a Novel Recombinant β-Glucuronidase in Benzodiazepine Urine Analysis”

  • A summary of “Accurate Quantitation of Heroin Metabolite, 6-Monoacetlymorphine in Urine Using IMCSzyme® for Hydrolysis”

  • A summary of “Ultra-Fast Quantification of Antidepressants in Urine at 9 Seconds Per Sample Using LDTD-MS/MS”

  • A summary of “Optimization of Extraction Parameters Using IMCSzyme®  β-Glucuronidase for Blood Opiate Analysis”

  • A summary of “Hydrolyze Your Way to Compliance – A Call for Pain Management Certified Reference Materials”

  • A summary of “Enzyme Hydrolysis of Haloperidol Glucuronide; A Major Urine Metabolite of Haldol®”

  • A summary of “Isomer interferences observed during the development of a 47-analyte HRAM LC-MS/MS method for urine drug testing”

  • A summary of “Meconium Targeted Drug Screening in 9 seconds per Sample Using Laser Diode Thermal Desorption Mass Spectrometry (LDTD-MS/MS)”

  • A summary of “ Development of an LC/MS-MS Naloxone Hydrolysis Assay Using a Recombinant Beta-Glucuronidase for Urinalysis”

  • A summary of “Opiate Hydrolysis by a Novel Recombinant  β-Glucuronidase for Urine Analysis”

  • A summary of “Enzyme Hydrolysis Using a Novel Recombinant β-Glucuronidase for Pain Management Urine Drug Testing”

  • A summary of “Screening and Quantification of Pain and Antidepressant Drugs in Human Urine by Liquid Chromatography-High Resolution Mass Spectrometry”

  • A summary of “LC-MS/MS Method for the Determination of Tricyclic and Tetracyclic Antidepressants in Human Urine”

  • A summary of “Fast Simple, and Accurate Method for Urine Drugs of Abuse Screening and Quantitation Using Liquid Chromatography with Time of Flight (TOF) Mass”

  • A summary of “Comparison of Novel β-Glucuronidases for Process Improvement in Urine Toxicology Workflows”

  • A summary of “Uromics: Metabolomics in Urine for Seroquel®, Latuda®, and Haldol®”

Webinars
  • Evaluation of two β-Glucuronidases for Urine Drug Testing
  • How Enzymes Fail: The Hidden Secrets of Urine-Induced Inhibition
  • Endogenous factors inhibiting β-Glucuronidases
  • Balancing Column Deterioration with Enzyme Performance for Drug of Abuse Hydrolysis
  • Reducing Analytical Complexity by the Application of Enzymes
Journal Articles Journal Summaries
Journal Articles
  1. Guterstam J, Tavic C, Barosso M, Beck O. (2024). A multicomponent LC-MS/MS method for drugs of abuse testing using volumetric DBS and a clinical evaluation by comparison with urine. Journal of Pharmaceutical and Biomedical Analysis. doi:10.1016/j.jpba.2024.116075
  2. Li X, Plotkina N, Bryksin J. (2023). Quantitation of Bupropion in Urine by Liquid Chromatography-Tandem Mass Spectrometry. In Clinical Applications of Mass Spectrometry in Drug Analysis: Methods and Protocols. New York, NY: Springer US. doi: 10.1007/978-1-0716-3541-4_11
  3. Lessard-Lord J, Auger S, Demers S, Plante PL, Picard P, Desjardins Y. (2023). Automated High-Throughput Quantification of Phenyl-γ-valerolactones and Creatinine in Urine by Laser Diode Thermal Desorption. Journal of Agricultural and Food Chemistry. doi: 10.1021/acs.jafc.3c03888
  4. Rosano TG, Cooper JA, Scholz KL, Wood M. (2023). Confirmation of cannabinoids in forensic toxicology casework by isomer-selective UPLC–MS-MS analysis in urine. Journal of Analytical Toxicology. doi:10.1093/jat/bkad048
  5. Lessard-Lord J, Plante PL, Desjardins Y. (2022). Purified recombinant enzymes efficiently hydrolyze conjugated urinary (poly)phenol metabolites. Food & Function. doi: 10.1039/d2fo02229j
  6. Rydberg M, Dowling S, Manicke NE. (2022). Automated and High-Throughput Urine Drug Screening Using Paper Spray Mass Spectrometry. Journal of Analytical Toxicology. doi: 10.1093/jat/bkac053.
  7. Helmer E, Karimian N, Van Assche K, Seghers I, Le Tallec S, Cherala G, Scott G, Namour FS. (2022). Ziritaxestat Drug–Drug Interaction with Oral Contraceptives: Role of SULT1E1 Inhibition. Clinical Pharmacology & Therapeutics. doi: 10.1002/cpt.2689
  8. Mata DC, Davis JF. (2022). Simultaneous quantitative analysis of 39 common toxicological drugs for increased efficiency in an ante- and postmortem laboratory. Forensic Science International, p.111246. doi: 10.1016/j.forsciint.2022.111246.
  9. Jagerdeo E, Auger S. (2022). Rapid screening procedures for a variety of complex forensic samples using a Laser Diode Thermal Desorption (LDTD) coupled to different mass spectrometers. Forensic Science International, p.111246. doi: 10.1002/rcm.9244.
  10. Reber JD, Karschner EL, Seither JZ, Knittel JL, Walterscheid JP. (2021). Screening and confirmation methods for the qualitative identification of nine phytocannabinoids in urine by LC-MS/MS. Clinical Biochemistry, 98, pp.54-62. doi: 10.1016/j.clinbiochem.2021.09.005.
  11. Feng S, Strickland E, Enders J, Roslawski M, McIntire T, McIntire G. (2021). Ritalinic acid in urine: Impact of age and dose. Practical Laboratory Medicine. doi: 10.1016/j.plabm.2021.e00258.
  12. Okoye NC, Greene DN, Johnson-Davis KL. (2021). Is the Confirmatory Test Always Right? Sometimes Immunoassays Know What They Are Talking About. The Journal of Applied Laboratory Medicine. doi: 10.1093/jalm/jfab097.
  13. Karakükcü Ç, Çıracı MZ, Kocer D, Faydalı MY, Serdar MA. (2021). Evaluation of optimal urine screening and confirmation cut-off values for opiates, at a national reference laboratory. Turkish Journal of Biochemistry. doi: 10.1515/tjb-2020-0614
  14. Lee LA, McGee AC, Sitasuwan P, Tomashek JJ, Riley C, Muñoz-Muñoz AC, Andrade L. (2021). Factors Compromising Glucuronidase Performance in Urine Drug Testing Potentially Resulting in False Negatives. Journal of Analytical Toxicology. doi: 10.1093/jat/bkab090.
  15. Rosano TG, Rumberger JM, Wood M. (2021). Matrix Normalization Techniques for Definitive Urine Drug Testing. Journal of Analytical Toxicology. doi: 10.1093/jat/bkab052.
  16. Zuo LS, Tang XY, Xiong F, Liu YP, Liu M, Ling CW, Sun TY, Ling W, Zhang ZQ, Chen YM. (2021). Isoflavone biomarkers are inversely associated with atherosclerosis progression in adults: a prospective study. The American Journal of Clinical Nutrition. doi: 10.1093/ajcn/nqab008.
  17. Schlachter CR, McGee AC, Sitasuwan PN, Horvath GC, Karri NG, Lee LA, Tomashek JJ. (2021). Variants of Glycosyl Hydrolase Family 2 β-Glucuronidases have Increased Activity on Recalcitrant Substrates. Enzyme and Microbial Technology. doi: 10.1016/j.enzmictec.2020.109742.
  18. Kennedy D, Dani M. (2020). Comparative Analysis of ELISA Immunoassay and LC-QTOF for Opiate Screening. Journal of Analytical Toxicology. doi: 10.1093/jat/bkz109.
  19. Krotulski AJ, Mohr AL, Logan BK. (2020). Emerging synthetic cannabinoids: development and validation of a novel liquid chromatography quadrupole time-of-flight mass spectrometry assay for real-time detection. Journal of Analytical Toxicology. doi: 10.1093/jat/bkz084.
  20. Krotulski AJ, Cannaert A, Stove C, Logan BK. (2020). The next generation of synthetic cannabinoids: Detection, activity, and potential toxicity of pent-4en and but-3en analogues including MDMB-4en-PINACA. Drug Testing and Analysis. doi: 10.1002/dta.2935.
  21. Sofalvi S, Lavins ES, Kaspar CK, Michel HM, Mitchell-Mata CL, Huestis MA, Apollonio LG. (2020). Development and Validation of an LC–MS-MS Method for the Detection of 40 Benzodiazepines and Three Z-Drugs in Blood and Urine by Solid-Phase Extraction. Journal of Analytical Toxicology, bkaa072. doi: 10.1093/jat/bkaa072
  22. Feng S, Ward LF, Parish B, Strickland EC, Enders JR, McIntire G. (2020). Dose Dependent Urine Concentrations of Gabapentin (Neurontin®). Journal of Pharmaceutical Research; 5(1):22-26. doi: 10.33140/jpr.05.01.05
  23. Rosano TG, Ohouo PY, Wood M. (2020). Application of High-Resolution UPLC–MSE/TOF Confirmation in Forensic Urine Drug Screening by UPLC–MS/MS. Journal of Analytical Toxicology; 43(5):353-63. doi: 10.1093/jat/bky106
  24. Muñoz-Muñoz AC, Pekol T, Schubring D, Hyland R, Johnson C, Andrade L. (2020). Characterization of an Amphetamine Interference from Gabapentin in an LC–HRMS Method. Journal of Analytical Toxicology, 44(1), 36-40. doi: 10.1093/jat/bkz046.
  25. Winborn J, Kerrigan S. (2019). Stability and Hydrolysis of Desomorphine-Glucuronide. Journal of Analytical Toxicology. doi: 10.1093/jat/bkz021. [Epub ahead of print]
  26. Kang MG, Lin HR. (2019).  Systematic Evaluation and Validation of Benzodiazepines Confirmation Assay Using LC-MS-MS. Journal of Analytical Toxicology; 43(2):96-103. doi: 10.1093/jat/bky071.
  27. Strickland EC, Cummings OT, McIntire GL, Mellinger AL. (2019). Development and Validation of a Novel All-Inclusive LC–MS-MS Designer Drug Method. Journal of Analytical Toxicology; 43(3):161-9. doi: 10.1093/jat/bky087.
  28. Sitasuwan P, Melendez C, Marinova M, Spruill M, Lee LA. (2019). Comparison of Purified β-glucuronidases in Patient Urine Samples Indicates a Lack of Correlation Between Enzyme Activity and Drugs of Abuse Metabolite Hydrolysis Efficiencies Leading to Potential False Negatives. Journal of Analytical Toxicology. 43(3):221-227. doi: 10.1093/jat/bky082
  29. Feng S, Ward L, Parish B, et al. (2019). Urine drug testing concentration ranges for select benzodiazepines. Journal of Analytical & Pharmaceutical Research; 8(1):8-13. doi: 10.15406/japlr.2019.08.00303
  30. Wang FR, Fei J, Yu XL, Zhao XC, Wang Q, Metavarayuth K. (2018). Advancing the Analysis of Terbutaline in Urine Samples Using Novel Enzyme Hydrolysis. Bioanalysis. doi: 10.4155/bio-2018-0145
  31. Muñoz-Muñoz AC, Pekol T, Schubring D, Johnson C, Andrade L. (2018). Identification of Novel Opioid Interferences using High-Resolution Mass Spectrometry. Journal of Analytical Toxicology; 42(1):6-16. doi: 10.1093/jat/bkx065. Open Access
  32. Cummings OT, Strickland EC, Enders JR, McIntire GL. (2018). Impact of β-Glucuronidase Mediated Hydrolysis on Haldol® Urinalysis. Journal of Analytical Toxicology; 42(4):214-219. doi: 10.1093/jat/bkx103.
  33. Enders JR, Smith JP, Feng S, Strickland EC, McIntire GL. (2018). Analytical considerations when developing an LC-MS/MS method for more than 30 analytes. The Journal of Applied Laboratory Medicine, 2(4), 543-554. doi: 10.1373/jalm.2017.024174
  34. Rasmussen NN, Barker A, Strathmann FG. (2018). Lowering the bar for mass spectrometry: a comparison between immunoassay and rapid time-of-flight for presumptive screening of drugs in urine. The Journal of Applied Laboratory Medicine, 2(4), 535-542. doi: 10.1373/jalm.2017.024166
  35. Feng S, Cummings OT, McIntire G. (2018). Zolpidem and Zolpidem Carboxylic Acid Results from Medication Monitoring. Journal of Analytical Toxicology; 42(7):491-5. doi: 10.1093/jat/bky033.
  36. Dwivedi P, Zhou X, Powell TG, Calafat AM, Ye X. (2018). Impact of enzymatic hydrolysis on the quantification of total urinary concentrations of chemical biomarkers. Chemosphere; 199:256-62. doi: 10.1016/j.chemosphere.2018.01.177.
  37. Johnson-Davis KL. (2018). Opiate & Benzodiazepine Confirmations: To Hydrolyze or Not to Hydrolyze is the Question. Journal of Applied Laboratory Medicine; 2(4):564. doi: 10.1373/jalm.2016.022947. Review Article.
  38. Taylor LL, Flint NA, Ma V, Hill BM, Clark CJ, Strathmann FG. (2017). Internal Hydrolysis Indicator for Sample Specific Monitoring of β-Glucuronidase Activity. Journal of Analytical Toxicology; 41(5):407-411. doi: 10.1093/jat/bkx027.
  39. DiBattista A, Rampersaud D, Lee H, Kim M, Britz-McKibbin P. (2017). High throughput screening method for systematic surveillance of drugs of abuse by multisegment injection–capillary electrophoresis–mass spectrometry. Analytical chemistry;89(21):11853-61.doi: 10.1021/acs.analchem.7b03590
  40. Rosano TG, Ohouo PY, Wood M. (2017). Screening with Quantification for 64 Drugs and Metabolites in Human Urine using UPLC–MS-MS Analysis and a Threshold Accurate Calibration. Journal of Analytical Toxicology; 41(6):536-46. doi: 10.1093/jat/bkx035.
  41. Yang HS, Wu AH, Lynch KL. (2016). Development and Validation of a Novel LC-MS/MS Opioid Confirmation Assay: Evaluation of β-glucuronidase Enzymes and Sample Cleanup Methods. Journal of Analytical Toxicology; 40(5):323-329. doi: 10.1093/jat/bkw026.
  42. Sitasuwan P, Melendez C, Marinova M, Mastrianni K, Darragh A, Ryan E, Lee LA. (2016). Degradation of Opioids and Opiates During Acid Hydrolysis Leads to Reduced Recovery Compared to Enzymatic Hydrolysis. Journal of Analytical Toxicology; 40(8):601-607. doi: 10.1093/jat/bkw085.
  43. Rosano TG, Ohouo PY, LeQue JJ, Freeto SM, Wood M. (2016). Definitive Drug and Metabolite Screening in Urine by UPLC–MS-MS Using a Novel Calibration Technique. Journal of Analytical Toxicology; 40(8):628-38. doi: 10.1093/jat/bkw050.
  44. Mastrianni KR, Lee LA, Brewer WE, Dongari N, Barna M, Morgan SL. (2016). Variations in enzymatic hydrolysis efficiencies for amitriptyline and cyclobenzaprine in urine. Journal of Analytical Toxicology; 40:732-737. doi: 10.1093/jat/bkw062.
  45. Morris AA, Chester SA, Strickland EC, McIntire GL. (2014). Rapid Enzymatic Hydrolysis Using a Novel Recombinant β-Glucuronidase in Benzodiazepine Urinalysis. Journal of Analytical Toxicology; 38(8):610-614. doi: 10.1093/jat/bku083.
Journal Summaries
  • A summary of “Fast, Simple Method for the Analysis of Benzodiazepines in Meconium and an Interlaboratory Method Comparison”

  • A summary of “Rapid Enzyme Hydrolysis Using a Novel Recombinant β-Glucuronidase in Benzodiazepine Urine Analysis”

  • A summary of "Evaluation of Enzymatic Hydrolysis Efficiencies for Amitriptyline and Cyclobenzaprine in Urine"

  • A summary of "Evaluation of  β-Glucuronidase Enzymes and Sample Cleanup Methods"

Sidebar

"*" indicates required fields

Name*
Address*
Email me a copy
Consent

ABOUT

ABOUT IMCS

CAREERS

QUALITY POLICY

RESEARCH AT IMCS

PRODUCTS

IMCSZYME

IMCSZYME RT

IMCSTIPS

PROTEINS, ENZYMES, RESINS

GLYCO REAGENTS

TERMS

TERMS OF USE

PRIVACY POLICY

STANDARD TERMS AND CONDITIONS

FCOI POLICY

CONNECT WITH US

IMCS, Inc. Headquarters
110 Centrum Drive
Irmo, SC 29063

  • IMCS LinkedIn Page
  • IMCS Facebook Page
  • IMCS Twitter Page

COPYRIGHT © 2025 · IMCS · ALL RIGHTS RESERVED ·

Return to top

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.
Cookie InfoACCEPT

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are as essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
CookieDurationDescription
__cf_bm30 minutesCloudflare set the cookie to support Cloudflare Bot Management.
li_gc5 months 27 daysLinkedin set this cookie for storing visitor's consent regarding using cookies for non-essential purposes.
lidc1 dayLinkedIn sets the lidc cookie to facilitate data center selection.
UserMatchHistory1 monthLinkedIn sets this cookie for LinkedIn Ads ID syncing.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
CookieDurationDescription
SRM_B1 year 24 daysUsed by Microsoft Advertising as a unique ID for visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
CookieDurationDescription
_clck1 yearMicrosoft Clarity sets this cookie to retain the browser's Clarity User ID and settings exclusive to that website. This guarantees that actions taken during subsequent visits to the same website will be linked to the same user ID.
_clsk1 dayMicrosoft Clarity sets this cookie to store and consolidate a user's pageviews into a single session recording.
_fbp3 monthsFacebook sets this cookie to display advertisements when either on Facebook or on a digital platform powered by Facebook advertising after visiting the website.
_ga1 year 1 month 4 daysGoogle Analytics sets this cookie to calculate visitor, session and campaign data and track site usage for the site's analytics report. The cookie stores information anonymously and assigns a randomly generated number to recognise unique visitors.
_ga_*1 year 1 month 4 daysGoogle Analytics sets this cookie to store and count page views.
_gat_gtag_UA_*1 minuteGoogle Analytics sets this cookie to store a unique user ID.
_gcl_au3 monthsGoogle Tag Manager sets the cookie to experiment advertisement efficiency of websites using their services.
_gid1 dayGoogle Analytics sets this cookie to store information on how visitors use a website while also creating an analytics report of the website's performance. Some of the collected data includes the number of visitors, their source, and the pages they visit anonymously.
_s30 minutesThis cookie is associated with Shopify's analytics suite.
_shopify_s30 minutesThis cookie is associated with Shopify's analytics suite.
_shopify_y1 year 1 month 4 daysThis cookie is associated with Shopify's analytics suite.
_y1 year 1 month 4 daysThis cookie is associated with Shopify's analytics suite.
AnalyticsSyncHistory1 monthLinkedin set this cookie to store information about the time a sync took place with the lms_analytics cookie.
CLID1 yearMicrosoft Clarity set this cookie to store information about how visitors interact with the website. The cookie helps to provide an analysis report. The data collection includes the number of visitors, where they visit the website, and the pages visited.
CONSENT2 yearsYouTube sets this cookie via embedded YouTube videos and registers anonymous statistical data.
ln_or1 dayLinkedin sets this cookie to registers statistical data on users' behaviour on the website for internal analytics.
MR7 daysThis cookie, set by Bing, is used to collect user information for analytics purposes.
SMsessionMicrosoft Clarity cookie set this cookie for synchronizing the MUID across Microsoft domains.
vuid1 year 1 month 4 daysVimeo installs this cookie to collect tracking information by setting a unique ID to embed videos on the website.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
CookieDurationDescription
ANONCHK10 minutesThe ANONCHK cookie, set by Bing, is used to store a user's session ID and verify ads' clicks on the Bing search engine. The cookie helps in reporting and personalization as well.
bcookie1 yearLinkedIn sets this cookie from LinkedIn share buttons and ad tags to recognize browser IDs.
bscookie1 yearLinkedIn sets this cookie to store performed actions on the website.
IDE1 year 24 daysGoogle DoubleClick IDE cookies store information about how the user uses the website to present them with relevant ads according to the user profile.
li_sugr3 monthsLinkedIn sets this cookie to collect user behaviour data to optimise the website and make advertisements on the website more relevant.
MUID1 year 24 daysBing sets this cookie to recognise unique web browsers visiting Microsoft sites. This cookie is used for advertising, site analytics, and other operations.
test_cookie15 minutesdoubleclick.net sets this cookie to determine if the user's browser supports cookies.
VISITOR_INFO1_LIVE5 months 27 daysYouTube sets this cookie to measure bandwidth, determining whether the user gets the new or old player interface.
VISITOR_PRIVACY_METADATA5 months 27 daysYouTube is a Google-owned platform for hosting and sharing videos. YouTube collects user data through videos embedded in websites, which is aggregated with profile data from other Google services in order to display targeted advertising to web visitors across a broad range of their own and other websites.
YSCsessionYoutube sets this cookie to track the views of embedded videos on Youtube pages.
yt-remote-connected-devicesneverYouTube sets this cookie to store the user's video preferences using embedded YouTube videos.
yt-remote-device-idneverYouTube sets this cookie to store the user's video preferences using embedded YouTube videos.
yt.innertube::nextIdneverYouTube sets this cookie to register a unique ID to store data on what videos from YouTube the user has seen.
yt.innertube::requestsneverYouTube sets this cookie to register a unique ID to store data on what videos from YouTube the user has seen.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT
Powered by CookieYes Logo

DOWNLOAD OUR POSTERS

"*" indicates required fields

Please select the posters you would like to download*
Name*
Please provide a valid email so we can send you the download link.
Location*
Automated Liquid Handling System
Contact preferences*
Consent*
This field is for validation purposes and should be left unchanged.

Podcast Form

"*" indicates required fields

Name*
How would you like to connect?*
Please let us know what's on your mind. Have a question for us? Ask away.

Ready for a change? Get your FREE sample of IMCSzyme® RT today.

"*" indicates required fields

Name*
Location*
Consent*
This field is for validation purposes and should be left unchanged.